Therapeuticsmd, INC. (TXMD) — 10-Q Filings

All 10-Q filings from Therapeuticsmd, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

TXMD Swings to Profit Amid Royalty Model Shift, Mayne Lawsuit Looms — Nov 12, 2025 Risk: high
TherapeuticsMD, Inc. (TXMD) reported a net income of $152 thousand for the three months ended September 30, 2025, a significant improvement from a net loss of $
TherapeuticsMD Swings to Profit Amid Royalty Model Shift, Legal Woes Persist — Aug 12, 2025 Risk: high
TherapeuticsMD, Inc. (TXMD) reported a net income of $551 thousand for the three months ended June 30, 2025, a significant improvement from a net loss of $1.090
TherapeuticsMD Files Q1 2025 10-Q — May 13, 2025 Risk: low
TherapeuticsMD, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as AMHN, Inc., is incorporated in
TherapeuticsMD Files Q3 2024 10-Q — Nov 12, 2024 Risk: low
TherapeuticsMD, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as AMHN, Inc., is incorporated in Nevada and operates
TherapeuticsMD Files Q2 2024 10-Q — Aug 12, 2024 Risk: low
TherapeuticsMD, Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as AMHN, Inc., is incorporated in Nevada and opera
TherapeuticsMD, Inc. Files 10-Q for Period Ended March 31, 2024 — May 10, 2024 Risk: low
TherapeuticsMD, Inc. (TXMD) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. TherapeuticsMD, Inc. filed a 10-Q report for the quarterly period ende

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX